CD16 anticorps

N° du produit ABIN320001

Cet anticorps anti-CD16 est un anticorps Rat Monoclonal détectant CD16 dans FACS et IHC (fro). Adapté pour Humain.

Aperçu rapide pour CD16 anticorps (ABIN320001)

Antigène: CD16

Reactivité: Humain

Hôte: Rat

Clonalité: Monoclonal

Conjugué: Cet anticorp CD16 est non-conjugé

Application: Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone: YFC120-5

Détail du produit anti-CD16 anticorps

Specificité: This antibody binds specifically to the leucocyte low affinity Fc receptor (Fc RIII), also known as CD16. It recognises a 50-70 kDa leucocyte surface antigen.

Purification: Affinity chromatography on Protein A.

Immunogène: Human neutrophils. Spleen cells from Lou rat fused with the rat myeloma cell line. Y3/Ag.1.2.3.

Isotype: IgG2b

Information d'application

Indications d'application: Flow Cytometry. Immunohistochemistry on Frozen Sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL

Buffer: PBS, pH 7.4 containing 0.09 % Sodium Azide as preservative.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur CD16

Antigène: CD16

Autre désignation: CD16

Sujet: The antigen is expressed by neutrophils, NK cells, K cells and a subpopulation of macrophages.Synonyms: CD16A, FCG3, FCGR3, FCGR3A, Fc-gamma RIII, Fc-gamma RIII-alpha, Fc-gamma RIIIa, FcR-10, FcRIII, FcRIIIa, IGFR3, IgG Fc receptor III-2, Low affinity immunoglobulin gamma Fc region receptor III-A

ID gène: 2214

NCBI Accession: NP_000560

UniProt: P08637

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process